Compare Organon Pharma Indonesia Tbk. (SCPI) vs Tower Bersama Infrastructure Tbk. (TBIG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Organon Pharma Indonesia Tbk. vs Tower Bersama Infrastructure Tbk. — how do they compare? Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B), while Tower Bersama Infrastructure Tbk. trades at Rp1,480 (market cap 33.65T, 357K 24h volume). The key difference: Tower Bersama Infrastructure Tbk. is far larger — about 322.3× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| SCPI | TBIG | |
|---|---|---|
Market Cap | 104.4B | 33.65T |
Volume | — | 357K |
Lot | — | 3.57K |
Turnover | — | 525.04M |
Average Price | — | 1,470.71 |
Value | — | 525.04M |
Indicative Equilibrium Price | — | 1,480 |
Indicative Equilibrium Volume | — | 25 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →About Tower Bersama Infrastructure Tbk.
PT Tower Bersama Infrastructure (the Company) was established under its original name of PT Banyan Mas on Nov 8th, 2004 then changed to PT Tower Bersama Infrastructure based on Notaries Deed dated Oct 24, 2009 and the deed of establishment was approved by the the Ministry of Justice dated Feb 13, 2008. The Company’s articles of association has been amended several times, most recently by notarial deed No. 145 of Aulia Taufani, S.H., dated Jul 21, 2010, concerning among others, the change in the Company’s name, equity, public company and for the amendments in the company's whole articles of Association to comply with the requirements of the Capital Market and Financial Institutions Supervisory Agency.
Read more on TBIG →
